Literature DB >> 20485912

Hypoparathyroidism: clinical features, skeletal microstructure and parathyroid hormone replacement.

Mishaela R Rubin1, John P Bilezikian.   

Abstract

OBJECTIVE: Hypoparathyroidism is a disorder in which parathyroid hormone is deficient in the circulation due most often to immunological destruction of the parathyroids or to their surgical removal. The objective of this work was to define the abnormalities in skeletal microstructure as well as to establish the potential efficacy of PTH(1-84) replacement in this disorder. SUBJECTS AND METHODS: Standard histomorphometric and microCT analyses were performed on iliac crest bone biopsies obtained from patients with hypoparathyroidism. Participants were treated with PTH(1-84) for two years.
RESULTS: Bone density was increased and skeletal features reflected the low turnover state with greater BV/TV, Tb. Wi and Ct. Wi as well as suppressed MS and BFR/BS as compared to controls. With PTH(1-84), bone turnover and bone mineral density increased in the lumbar spine. Requirements for calcium and vitamin D fell while serum and urinary calcium concentrations did not change.
CONCLUSION: Abnormal microstructure of the skeleton in hypoparathyroidism reflects the absence of PTH. Replacement therapy with PTH has the potential to correct these abnormalities as well as to reduce the requirements for calcium and vitamin D.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20485912      PMCID: PMC3702727          DOI: 10.1590/s0004-27302010000200019

Source DB:  PubMed          Journal:  Arq Bras Endocrinol Metabol        ISSN: 0004-2730


  20 in total

Review 1.  Clinical practice. Hypoparathyroidism.

Authors:  Dolores Shoback
Journal:  N Engl J Med       Date:  2008-07-24       Impact factor: 91.245

2.  Calcium-regulating hormones and the kidney.

Authors:  K Kurokawa
Journal:  Kidney Int       Date:  1987-11       Impact factor: 10.612

3.  Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism.

Authors:  K K Winer; J A Yanovski; G B Cutler
Journal:  JAMA       Date:  1996-08-28       Impact factor: 56.272

4.  Clinical variation of autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy (APECED) in a series of 68 patients.

Authors:  P Ahonen; S Myllärniemi; I Sipilä; J Perheentupa
Journal:  N Engl J Med       Date:  1990-06-28       Impact factor: 91.245

5.  Three dimensional cancellous bone structure in hypoparathyroidism.

Authors:  Mishaela R Rubin; David W Dempster; Thomas Kohler; Martin Stauber; Hua Zhou; Elizabeth Shane; Thomas Nickolas; Emily Stein; James Sliney; Shonni J Silverberg; John P Bilezikian; Ralph Müller
Journal:  Bone       Date:  2009-09-25       Impact factor: 4.398

6.  Therapy of hypoparathyroidism with intact parathyroid hormone.

Authors:  M R Rubin; J Sliney; D J McMahon; S J Silverberg; J P Bilezikian
Journal:  Osteoporos Int       Date:  2010-01-22       Impact factor: 4.507

Review 7.  Anti-parathyroid and anti-calcium sensing receptor antibodies in autoimmune hypoparathyroidism.

Authors:  Edward M Brown
Journal:  Endocrinol Metab Clin North Am       Date:  2009-06       Impact factor: 4.741

8.  Deterioration of renal function during treatment of chronic renal failure with 1,25-dihydroxycholecalciferol.

Authors:  C Christiansen; P Rødbro; M S Christensen; B Hartnack; I Transbøl
Journal:  Lancet       Date:  1978-09-30       Impact factor: 79.321

9.  A randomized, cross-over trial of once-daily versus twice-daily parathyroid hormone 1-34 in treatment of hypoparathyroidism.

Authors:  K K Winer; J A Yanovski; B Sarani; G B Cutler
Journal:  J Clin Endocrinol Metab       Date:  1998-10       Impact factor: 5.958

10.  Bone mineral density in patients with chronic hypoparathyroidism.

Authors:  S Abugassa; J Nordenström; S Eriksson; G Sjödén
Journal:  J Clin Endocrinol Metab       Date:  1993-06       Impact factor: 5.958

View more
  20 in total

Review 1.  Mini-review: new therapeutic options in hypoparathyroidism.

Authors:  Natalie E Cusano; Mishaela R Rubin; James Sliney; John P Bilezikian
Journal:  Endocrine       Date:  2012-02-07       Impact factor: 3.633

2.  Low bone turnover and increase of bone mineral density in a premenopausal woman with postoperative hypoparathyroidism and thyroxine suppressive therapy.

Authors:  K Amrein; H P Dimai; H Dobnig; A Fahrleitner-Pammer
Journal:  Osteoporos Int       Date:  2010-10-20       Impact factor: 4.507

3.  Potential treatment of hypoparathyroidism with recombinant plasmids encoding preproparathyroid hormone.

Authors:  D Liu; Y Zhu; C Yang; J Long; C Yao; J Li; S Wang
Journal:  J Endocrinol Invest       Date:  2011-09-27       Impact factor: 4.256

Review 4.  Recombinant Human Parathyroid Hormone (1-84): A Review in Hypoparathyroidism.

Authors:  Esther S Kim; Gillian M Keating
Journal:  Drugs       Date:  2015-07       Impact factor: 9.546

5.  Therapy of hypoparathyroidism with PTH(1-84): a prospective four-year investigation of efficacy and safety.

Authors:  Natalie E Cusano; Mishaela R Rubin; Donald J McMahon; Chiyuan Zhang; Rebecca Ives; Amanda Tulley; James Sliney; Serge C Cremers; John P Bilezikian
Journal:  J Clin Endocrinol Metab       Date:  2012-11-15       Impact factor: 5.958

Review 6.  Use of parathyroid hormone in hypoparathyroidism.

Authors:  N E Cusano; M R Rubin; D Irani; J Sliney; J P Bilezikian
Journal:  J Endocrinol Invest       Date:  2013-12       Impact factor: 4.256

7.  Calcium, vitamin D or recombinant parathyroid hormone for managing post-thyroidectomy hypoparathyroidism.

Authors:  Ovie Edafe; Claudia E Mech; Sabapathy P Balasubramanian
Journal:  Cochrane Database Syst Rev       Date:  2019-05-22

Review 8.  Hypocalcemia: updates in diagnosis and management for primary care.

Authors:  Jeremy Fong; Aliya Khan
Journal:  Can Fam Physician       Date:  2012-02       Impact factor: 3.275

Review 9.  New understanding and treatments for osteoporosis.

Authors:  G Mazziotti; J Bilezikian; E Canalis; D Cocchi; A Giustina
Journal:  Endocrine       Date:  2012-02       Impact factor: 3.633

10.  Expression of osteogenic molecules in the caudate nucleus and gray matter and their potential relevance for Basal Ganglia calcification in hypoparathyroidism.

Authors:  Ravinder Goswami; Tabin Millo; Shruti Mishra; Madhuchhanda Das; Mansi Kapoor; Neeraj Tomar; Soma Saha; Tara Shankar Roy; Vishnubhatla Sreenivas
Journal:  J Clin Endocrinol Metab       Date:  2014-02-19       Impact factor: 5.958

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.